Due to an increase in life span in the last 150 years, we are expecting to see the size of the global aging population increase dramatically in coming years. Ageing brings changes in the way our immune system works, which can have an impact on many areas of health. Through nutrition, we may be able to help maintain a healthy immune system into our later years. This three-part white paper provides all the information you need on how our immune system works and ways foods may support its healthy function.
The authors of this white paper are experts in the field of immunology. Dr. Fiona McEvoy and Dr. Christine Loscher are researchers in the Immunomodulation Research Group at Dublin City University, where they study the role of nutrition in immune health. Click the links below to read each section of the paper.
Part 1 provides a brief introduction into the scope of ageing worldwide and the impact ageing can have on the function of our immune system.
In Part 2, the authors take a look at the specific mechanisms of the immune system and how our innate and adaptive immune cells protect our bodies. A great read for those seeking a deep-dive into how the immune system works. If this section is more in-depth than you expected, just move on to Part 3!
This part of the white paper explores the evidence for the role of specific nutrients, including vitamin D, protein, and omega 3 fatty acids, in supporting immune health as we age and how we may be able to incorporate these benefits into targeted foods.
Do you want to stay up-to-date with the latest in science-based nutrition?
(You will receive 1 monthly email updating you on our new content)
Fiona McEvoy, PhD
Fiona McEvoy, PhD is a postdoctoral researcher at Dublin City University. Her studies primarily focus on identifying novel compounds that can modulate the immune system to provide therapeutic benefits using in vitro and in vivo models.
Christine Loscher, PhD
Christine Loscher, PhD is an Associate Professor of Immunology at Dublin City University. She is also the Lead Investigator of the Immunomodulation Research Group and has developed significant expertise in commercial research and industry engagement. She has secured over €4.5M in external funding for her research.